Menu Back toCMC Considerations for Accelerated Development of Advanced Therapy Products
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations
CMC Considerations for Accelerated Development of Advanced Therapy Products
Jun Park, PhD
- EVP/Chief Technology Officer
- ILIAS Biologics, Inc., Korea, Republic of